Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

Compare

70.03

-1.16 (-1.63%)

At close: Nov 14, 2025, 4:00 PM EST

70.10

+0.07 (0.10%)

After-hours: Nov 14, 2025, 7:48 PM EST

Halozyme Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1,243	1,015	829.25	660.12	443.31	267.59	Upgrade
Revenue Growth (YoY)	31.19%	22.44%	25.62%	48.91%	65.66%	36.53%	Upgrade
Cost of Revenue	262.09	238.47	268.72	205.91	117.09	77.6	Upgrade
Gross Profit	980.76	776.86	560.53	454.21	326.23	189.99	Upgrade
Selling, General & Admin	172.31	154.34	149.18	121.63	50.32	45.74	Upgrade
Amortization of Goodwill & Intangibles	71.05	71.05	71.27	43.15	-	-	Upgrade
Operating Expenses	243.36	225.38	220.46	164.77	50.32	45.74	Upgrade
Operating Income	737.4	551.48	340.07	289.43	275.9	144.26	Upgrade
Interest Expense	-17.76	-18.1	-18.76	-16.95	-7.53	-20.38	Upgrade
Interest & Investment Income	20.77	12.83	10	3.88	3.36	5.43	Upgrade
EBT Excluding Unusual Items	740.41	546.21	331.31	276.36	271.74	129.3	Upgrade
Merger & Restructuring Charges	-	-	-	-21.9	-	-	Upgrade
Gain (Loss) on Sale of Investments	5.53	10.93	6.32	-2.83	-2.26	-	Upgrade
Asset Writedown	-	-	-2.5	-	-	-	Upgrade
Other Unusual Items	-	-	13.2	-2.71	-20.96	-	Upgrade
Pretax Income	745.94	557.13	348.33	248.92	248.52	129.3	Upgrade
Income Tax Expense	150.45	113.04	66.74	46.79	-154.19	0.22	Upgrade
Net Income	595.49	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income to Common	595.49	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income Growth	51.73%	57.71%	39.31%	-49.81%	211.97%	-	Upgrade
Shares Outstanding (Basic)	122	127	132	137	141	136	Upgrade
Shares Outstanding (Diluted)	126	129	134	141	147	141	Upgrade
Shares Change (YoY)	-3.31%	-3.56%	-4.56%	-4.21%	3.77%	-1.99%	Upgrade
EPS (Basic)	4.88	3.50	2.13	1.48	2.86	0.95	Upgrade
EPS (Diluted)	4.74	3.43	2.10	1.44	2.74	0.91	Upgrade
EPS Growth	56.68%	63.33%	45.83%	-47.45%	201.10%	-	Upgrade
Free Cash Flow	602.4	468.37	373.28	235.3	297.98	52.95	Upgrade
Free Cash Flow Per Share	4.80	3.62	2.78	1.67	2.03	0.37	Upgrade
Gross Margin	78.91%	76.51%	67.59%	68.81%	73.59%	71.00%	Upgrade
Operating Margin	59.33%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Profit Margin	47.91%	43.74%	33.96%	30.62%	90.84%	48.24%	Upgrade
Free Cash Flow Margin	48.47%	46.13%	45.01%	35.64%	67.22%	19.79%	Upgrade
EBITDA	813.28	627.09	416.93	336.07	277.3	145.84	Upgrade
EBITDA Margin	65.44%	61.76%	50.28%	50.91%	62.55%	54.50%	Upgrade
D&A For EBITDA	75.89	75.61	76.86	46.64	1.4	1.58	Upgrade
EBIT	737.4	551.48	340.07	289.43	275.9	144.26	Upgrade
EBIT Margin	59.33%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Effective Tax Rate	20.17%	20.29%	19.16%	18.80%	-	0.17%	Upgrade
Revenue as Reported	1,243	1,015	829.25	660.12	443.31	267.59	Upgrade

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q